Bionano Genomics Inc. (BNGO) Recovers 1688.37% From Low: Sitting In The Catbird Seat? – Stocks Register
Home  »  Business   »  Bionano Genomics Inc. (BNGO) Recovers 1688.37% Fro...

Bionano Genomics Inc. (BNGO) Recovers 1688.37% From Low: Sitting In The Catbird Seat?

Bionano Genomics Inc. (NASDAQ:BNGO) at last check was buoying at $7.69 on Friday, June 18, with a fall of -2.16% from its closing price on previous day.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Taking a look at stock we notice that its last check on previous day was $7.86 with its price kept floating in the range of $7.60 and $8.12 on the day. Considering stock’s 52-week price range provides that BNGO hit a high price of $15.69 and saw its price falling to a low level of $0.43 during that period. Over a period of past 1-month, stock came adding 35.05% in its value.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


With its current market valuation of $2.21 billion. Analysts are in estimates of -$0.04 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$0.18 for 2021 with estimates of that growing to -$0.21 in next year. These estimates are suggesting current year growth of 53.80% for EPS and -16.70% growth next year.

Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $3.52 million. They suggested that in the process company could generate revenue of as low as $3.3 million which could climb up to $3.73 million to hit a high. The average estimate is representing an increase of 197.80% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $16.05 million in 2021, which will be 88.80% more from revenue generated by the company last year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review BNGO stock’s current outlook then short term indicators are assigning it an average of 50% Buy, while medium term indicators are categorizing the stock at an average of Hold. Long term indicators are suggesting an average of 50% Buy for it.

According to ratings assigned by 4 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 0 of them are recommending Bionano Genomics Inc. (BNGO) as a Hold, while 4 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.

Digging deeper we become aware of the PEG ratio of the BNGO stock which is currently positioned at 0. It further provides that stock’s current price level is 12.16% away from its 20-day simple moving average and is 21.37% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 58.74 while volatility remained at 7.20% over the past week which changes to 8.91% when measuring it over the past month. Measure of average true range or ATR is currently at 0.67. In predicting price targets of as low as $10.00 and as high as $14.00, analysts are in agreement on assigning the stock over the next 12 months average price target of $11.50. Stock’s current price level is -30.04% above from estimated low price target while it is -82.05% below the estimated high; and even if the BNGO’s share succeeded to reach the median price of $11.00, then the outlook of -43.04% could come to the excitement of the investors.

Having a second look at Bionano Genomics Inc. (NASDAQ:BNGO) provides that stock’s average daily trading volume for 3 months was 23.71 million, while it jumped to 21.11 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 278.79 million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

The percentage of outstanding shares held by the insiders is 0.30% while it is 15.50% for the institutional holders. The figures also indicate that as of May 27, 2021, number of stock’s short shares was 38.52 million which implies a short ratio of 1.65. This shows up a 13.81% of Short Interest in company’s outstanding shares on the day. In May the standing of shares short improved as it was 31.53 million in the previous month. Addition of 155.19% by stock’s current price to its year-to-date value in today’s trading is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.

Leave a Comment

Your email address will not be published. Required fields are marked *

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam